These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 22522858)

  • 1. The potential role of vitamin D in the progression of benign and malignant melanocytic neoplasms.
    Pinczewski J; Slominski A
    Exp Dermatol; 2010 Oct; 19(10):860-4. PubMed ID: 20872994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging perspectives: unraveling the anticancer potential of vitamin D
    Wakle KS; Mokale SN; Sakle NS
    Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):2877-2933. PubMed ID: 37994947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel vitamin D compounds and skin cancer prevention.
    Tongkao-On W; Gordon-Thomson C; Dixon KM; Song EJ; Luu T; Carter SE; Sequeira VB; Reeve VE; Mason RS
    Dermatoendocrinol; 2013 Jan; 5(1):20-33. PubMed ID: 24494039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective inhibition of cyclooxygenase-2 (COX-2) by 1alpha,25-dihydroxy-16-ene-23-yne-vitamin D3, a less calcemic vitamin D analog.
    Aparna R; Subhashini J; Roy KR; Reddy GS; Robinson M; Uskokovic MR; Venkateswara Reddy G; Reddanna P
    J Cell Biochem; 2008 Aug; 104(5):1832-42. PubMed ID: 18348265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 25-Hydroxyvitamin D3, the prohormone of 1,25-dihydroxyvitamin D3, inhibits the proliferation of primary prostatic epithelial cells.
    Barreto AM; Schwartz GG; Woodruff R; Cramer SD
    Cancer Epidemiol Biomarkers Prev; 2000 Mar; 9(3):265-70. PubMed ID: 10750664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
    Chen TC; Schwartz GG; Burnstein KL; Lokeshwar BL; Holick MF
    Clin Cancer Res; 2000 Mar; 6(3):901-8. PubMed ID: 10741714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vitamin D and cancer: antineoplastic effects of 1α,25(OH)2-vitamin D3].
    González Pardo V; Boland R; Russo de Boland A
    Medicina (B Aires); 2012; 72(2):143-9. PubMed ID: 22522858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anti-cancer actions of vitamin D.
    Chiang KC; Chen TC
    Anticancer Agents Med Chem; 2013 Jan; 13(1):126-39. PubMed ID: 23094926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antineoplastic effects of 1,25(OH)2D3 and its analogs in breast, prostate and colorectal cancer.
    Leyssens C; Verlinden L; Verstuyf A
    Endocr Relat Cancer; 2013 Apr; 20(2):R31-47. PubMed ID: 23319494
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.